Journal profile · Medicine-Neurology (clinical)
npj Parkinsons Disease
ISSN 2373-8057 · Springer Nature · ENGLAND · Founded 2015
npj Parkinsons Disease: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 8.42; fully open access; APC about USD 4,090; median 159 days to acceptance (118 articles, last 24 months); 385 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
npj Parkinsons Disease is published by Springer Nature and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments and Nuclear Receptors and Signaling, together about 58.2% of its articles. Its main subfields are Neurology. (generated from OpenAlex topic counts and CAS ranking data)
• Led by Parkinson's disease experts, collaborate to cultivate quality research • Published with Parkinson's Foundation • Offering a fully OA & more inclusive journal choice to Nature Portfolio authors The npj journals are published in close partnership with scientific communities, combining community focus with high‑quality editorial support. Covering disciplines from the physical and applied sciences to the life, health, social and environmental sciences, each npj journal is shaped through collaboration with the research community it serves.
Source: LetPub
Research area (LetPub): Medicine-Neurology (clinical)
Main research topics OpenAlex counts of recent articles; shares are approximate
- Parkinson's Disease Mechanisms and TreatmentsMedicine36.5%
- Neurological disorders and treatmentsMedicine18.2%
- Nuclear Receptors and SignalingNeuroscience3.5%
- Genetic Neurodegenerative DiseasesNeuroscience3.3%
- Alzheimer's disease research and treatmentsMedicine2.8%
- Transcranial Magnetic Stimulation StudiesNeuroscience2.6%
- Neuroinflammation and Neurodegeneration MechanismsNeuroscience2.6%
- Neurological diseases and metabolismNeuroscience2.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Neurosciences | Zone 2 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Neurosciences | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Neurosciences | Zone 1 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 8.42LetPub ·
- CiteScore 2026-06
- 11.1LetPub ·
- SJR 2026-06
- 2.84LetPub ·
- SNIP 2026-06
- 1.99LetPub ·
- h-index
- 88OpenAlex ·
- i10-index
- 816OpenAlex ·
- 2-year mean citedness
- 7.83OpenAlex ·
- Self-citation rate
- 8.2%LetPub ·
- Share of gold OA articles
- 99.87%LetPub ·
Volume
- Articles per year
- 372LetPub ·
Articles by year OpenAlex count · 1,601 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 334 | 334 | 182 |
| 2025 | 385 | 385 | 2,880 |
| 2024 | 236 | 236 | 4,415 |
| 2023 | 169 | 169 | 5,112 |
| 2022 | 176 | 176 | 7,188 |
| 2021 | 119 | 119 | 5,916 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
159 daysMedian, submission to acceptance · P25–P75 102 days – 227 days
- Acceptance to online
- median 20 days (118 articles)
- Submission to online
- median 176 days
- Sample
- 118 articles with submission and acceptance dates (767 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 11 weeksLetPub ·
- Submission to publication (journal-reported)
- about 11 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 3,290 / USD 4,090 / GBP 2,990 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 3,890 / EUR 3,190 / GBP 2,890 | — | — | |
| LetPub | GBP 2,690 / USD 3,590 / EUR 2,990 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Country or region
- ENGLAND
- Language
- English
- Founded
- 2015
- ISSN
- 2373-8057
- Official links
- Journal homepage ↗OpenAlex
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about npj Parkinsons Disease
What CAS zone is npj Parkinsons Disease in?
In the 2025 upgraded edition of the CAS Journal Ranking, npj Parkinsons Disease is in Zone 1 of Medicine, and in Zone 2 of the minor category Neurosciences; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of npj Parkinsons Disease?
The latest impact factor listed by LetPub is 8.42; CiteScore 11.1, h-index 88.
How long does peer review take at npj Parkinsons Disease?
Based on the dates recorded on 118 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 159 days (interquartile range 102–227 days); authors report an average review time of about 11 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index npj Parkinsons Disease?
According to LetPub and DOAJ records, npj Parkinsons Disease is indexed in SCIE, Scopus and DOAJ.
Is npj Parkinsons Disease open access, and what is the APC?
npj Parkinsons Disease is a fully open-access journal. APC about USD 4,090.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .